Agn-201904
2-[4-[5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-yl]sulfonylphenoxy]acetic acid
Molecular Identity
Agn-201904
2-[4-[5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-yl]sulfonylphenoxy]acetic acid
PubChem CID: 9829253
2D Structure
Properties
C25H25N3O8S2
Molecular Formula
559.60
Molecular Weight
g/mol
559.1083
Exact Mass
Da
2.9
XLogP
Drug-like (Lipinski: < 5)
175
TPSA
May have limited oral absorption
1
H-Bond Donors
11
H-Bond Acceptors
939
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2S(=O)(=O)C4=CC=C(C=C4)OCC(=O)O)C=CC(=C3)OCIsomeric SMILES
SMILES: CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2S(=O)(=O)C4=CC=C(C=C4)OCC(=O)O)C=CC(=C3)OCSynonyms(20)
AGN-201904651729-53-2G0835O03ZMAcetic acid, 2-(4-((5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazol-1-yl)sulfonyl)phenoxy)-AGN 201904RefChem:110185AGN201904-ZAGN2019042-(4-((5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl)-1H-1,3-benzodiazol-1-yl)sulfonyl)phenoxy)acetic acidUNII-G0835O03ZM2-[4-[5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-yl]sulfonylphenoxy]acetic acidorb1703794SCHEMBL2245875CHEMBL4297346SCHEMBL29596867
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Agn-201904
Loading drug network...